Letters, Testimony & Comments

Fri, 2014-03-07 18:15
  March 7, 2014   BY ELECTRONIC DELIVERY   Marilyn B. Tavenner Administrator Centers for Medicare & Medicaid Services U.S. Department of Health and Human Services Hubert H. Humphrey Building, Room 445-G 200...
Fri, 2014-03-07 17:04
On March 7, 2014, BIO submitted comments to the U.S. Office of Personnel Management (OPM) regarding OPM’s February 4, 2014 Multi-State Plan (MSP) Program Call Letter.  BIO’s comments address the critical nature of the Affordable...
Tue, 2014-03-04 18:20
March 4, 2014 Regulatory Analysis and Development PPD, APHIS Station 3A-03.8 4700 River Road Unit 118 Riverdale, MD 20737-1238   Re: U.S. Department of Agriculture Docket No. APHIS-2013-0047   Dear Sir or Madam:...
Tue, 2014-03-04 00:00
  Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the “Request for Nominations: Drug Products that Present Demonstrable...
Tue, 2014-02-25 13:32
Stanford McCoy Assistant U.S. Trade Representative for Intellectual Property and Innovation Office of the U.S. Trade Representative Chair of the Special 301 Committee Office of the United States Trade Representative Washington, D.C....
Tue, 2014-02-25 00:00
BIO joined with the American Pharmacists Association (APhA), Association of State and Territorial Health Officials (ASTHO), Immunization Action Coalition (IAC), Merck, and the National Association of County and City Health Officials (NACCHO) to...
Mon, 2014-02-24 17:49
Good morning. My name is Lila Feisee, Vice President of International Affairs at the Biotechnology Industry Organization (BIO).  Today, I am testifying on behalf of BIO and its 1100 members who innovate in the healthcare, agriculture,...
Mon, 2014-02-24 00:00
Dear Sir or Madam:   The Pharmaceutical Research and Manufacturers of America (PhRMA) and Biotechnology Industry Organization (BIO) are pleased to submit these comments in response to the Food and Drug Administration’s (FDA’s...
Wed, 2014-02-12 14:17
On behalf of the Biotechnology Industry Organization (BIO), I hereby submit comments on the Senate Committee on Finance staff discussion draft to reform certain energy tax provisions. BIO is the world's largest trade association representing...
Wed, 2014-02-12 12:41
The Honorable David Borden, Committee Chair The Honorable Charles Townsend, Committee Vice-Chair And the Members of the Science, Technology & Energy Committee: Chairman Borden, Vice Chairman Townsend, and Members of the Committee, the...
Mon, 2014-02-03 00:00
 Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the “Draft Guidance for Industry on Pharmacy Compounding of Human Drug Products...
Fri, 2014-01-31 16:43
Dear Ms. Badrov: The Biotechnology Industry Organization (BIO) and the Illinois Biotechnology Industry Organization (iBIO) appreciate this opportunity to comment on the Illinois Department of Healthcare and Family Services (the “Department...
Fri, 2014-01-31 16:37
Dear Ms. Gibson: To Whom It May Concern: The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the Texas Health and Human Services Commission (HHSC) proposed rule regarding 340B program reimbursement (the...
Fri, 2014-01-31 00:00
Dear Sir/Madam: The Biotechnology Industry Organization (BIO) respectfully submits these comments in response to the Generic Pharmaceutical Association (GPhA) Citizen Petition requesting the Food and Drug Administration (FDA) to “implement...
Wed, 2014-01-29 13:47
  January 28, 2014   The Honorable Gina McCarthy Administrator, Environmental Protection Agency Air and Radiation Docket and Information Center Mailcode: 2822T 1200 Pennsylvania Avenue NW Washington, DC  20460   Docket...
Wed, 2014-01-22 00:00
 Dear Commissioner Hamburg and Director Burwell: On behalf of the member companies of Biotechnology Industry Organization (BIO), we respectfully request that the Office of Management and Budget (OMB) issue the proposed Food and Drug...
Tue, 2014-01-21 16:54
Advancing Bioscience Industry Growth in Michigan: 2014 Best Practice Legislative Strategies To the Honorable Members of the 2014 Michigan Legislature: Thank you for providing BIO an opportunity to speak with you this morning and offer best...
Fri, 2014-01-03 00:00
 Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the “Proposed Rule: Permanent Discontinuance or Interruption in Manufacturing of...
Thu, 2013-12-19 12:31
On November 15, 2013, BIO submitted comments to the Centers for Medicare and Medicaid Services (CMS) regarding their Federally Qualified Health Center (FQHC) Prospective Payment System (PPS) proposed rule.    BIO’s comments...